celiprolol has been researched along with Hypoxia in 1 studies
Celiprolol: A cardioselective beta-1 adrenergic antagonist that has intrinsic sympathomimetic activity. It is used in the management of ANGINA PECTORIS and HYPERTENSION.
Hypoxia: Sub-optimal OXYGEN levels in the ambient air of living organisms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nishioka, S | 1 |
| Yoshioka, T | 1 |
| Nomura, A | 1 |
| Kato, R | 1 |
| Miyamura, M | 1 |
| Okada, Y | 1 |
| Ishizaka, N | 1 |
| Matsumura, Y | 1 |
| Hayashi, T | 1 |
1 other study available for celiprolol and Hypoxia
| Article | Year |
|---|---|
Celiprolol reduces oxidative stress and attenuates left ventricular remodeling induced by hypoxic stress in mice.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Blood Pressure; Celiprolol; Heart; Heart Rate; Hypo | 2013 |